Medical management of patients with brain tumors.

Current Treatment Options in Neurology
Amy A Pruitt

Abstract

Patients with brain tumors require meticulous attention to medical issues resulting from their disease or its therapy. The following specific issues are the ones most frequently arising in the purview of neurologists: (1) Vasogenic edema: Corticosteroids should be used in divided doses in the minimum amount required to control symptoms and should be tapered as quickly as possible. Some patients may require long-term steroid supplementation, and symptoms of adrenal insufficiency should be investigated with 8 AM: cortisol measurement and treated with appropriate repletion. (2) Seizures: Patients with brain tumors should receive antiepileptic drugs only if they have had seizures, and the drugs should be chosen to minimize cognitive effects and interactions with concurrently administered chemotherapy. Levetiracetam is an excellent choice for patients with partial seizures and is available both orally and parenterally. Lamotrigine is another reasonable choice but requires slow titration. (3) Venous thromboembolism: All brain tumor patients should receive perioperative venous thrombosis prophylaxis with compression boots and enoxaparin or dalteparin. Lifelong treatment with low molecular weight heparinoids or warfarin is required for...Continue Reading

References

Jul 17, 1998·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·C A MeyersV A Levin
Aug 6, 1999·Journal of Thrombosis and Thrombolysis·A T ChanS Z Goldhaber
Feb 16, 2000·Lancet·A Fugh-Berman
Oct 5, 2001·Current Opinion in Pulmonary Medicine·D C Walsh, A K Kakkar
Dec 26, 2001·JAMA : the Journal of the American Medical Association·J A KovacsH Masur
Jan 12, 2002·JAMA : the Journal of the American Medical Association·Douglas B Coursin, Kenneth E Wood
Jul 24, 2002·Journal of Neurosurgery·Christopher J Watling, J Gregory Cairncross
Dec 3, 2002·Annals of Internal Medicine·Wendy A WeigerDavid M Eisenberg
Feb 21, 2003·The New England Journal of Medicine·Mark S Cooper, Paul M Stewart
Aug 2, 2003·Journal of Neuro-oncology·Anuj K Mahindra, Stuart A Grossman
Nov 25, 2003·Annals of Oncology : Official Journal of the European Society for Medical Oncology·A PaceC M Carapella
Jun 18, 2004·Journal of Neurosurgery·Ossama Al-MeftyMichael J Harrison
Oct 29, 2004·Current Treatment Options in Oncology·Mary Ann Knovich, Glenn J Lesser
Jan 1, 2005·Current Opinion in Oncology·Evert C A Kaal, Charles J Vecht
Mar 22, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Edward G ShawStephen R Rapp
Jun 30, 2006·Journal of Neuro-oncology·Patrick Y WenLisa Doherty
Oct 13, 2006·The New England Journal of Medicine·Kevin C OeffingerUNKNOWN Childhood Cancer Survivor Study
Nov 23, 2006·Hematology/oncology Clinics of North America·Tracy T Batchelor, Thomas N Byrne
Dec 13, 2006·Neurology·Sean A GrimmLisa M DeAngelis
Sep 13, 2007·JAMA : the Journal of the American Medical Association·Gordon J WoodJamie H Von Roenn
Oct 31, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Gary H LymanUNKNOWN American Society of Clinical Oncology
Apr 26, 2008·Neuro-oncology·Phioanh Leia NghiemphuTimothy F Cloughesy
Jun 3, 2008·International Journal of Radiation Oncology, Biology, Physics·Jan DrappatzPatrick Y Wen
Sep 2, 2008·The Lancet Oncology·Susan CattLesley Fallowfield
Oct 24, 2008·The New England Journal of Medicine·Jong Woo LeeSantosh Kesari
Apr 22, 2009·Annals of Internal Medicine·Jennifer Fisher Wilson
May 13, 2009·Journal of Neurology·Mèlanie S M van BreemenCharles J Vecht
Aug 26, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Maurizio ZangariGuido J Tricot
Sep 10, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Michael B Streiff
Nov 17, 2009·Journal of Thrombosis and Haemostasis : JTH·E O JenkinsN S Key
Dec 2, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Areej El-JawahriAngelo E Volandes
Dec 19, 2009·Neurology·Kristen L TriebelDaniel C Marson
Jan 13, 2010·Cancer·Nancy L KeatingKatherine L Kahn
Aug 14, 2010·Current Opinion in Oncology·Andrea PaceAlessandra Fabi

❮ Previous
Next ❯

Citations

Nov 16, 2012·Bulletin of Mathematical Biology·Alicia Martínez-GonzálezVíctor M Pérez-García
Nov 7, 2012·Annals of Oncology : Official Journal of the European Society for Medical Oncology·Y-L WuJ-J Yang
Jul 20, 2012·Continuum : Lifelong Learning in Neurology·Jan Drappatz
Nov 1, 2012·CNS Oncology·Jaime Gállego Pérez-Larraya, Jean-Yves Delattre
Aug 15, 2014·Journal of Neuro-oncology·Katherine B PetersLee W Jones
Aug 21, 2013·Current Psychiatry Reports·Rosangela CarusoMichelle Riba
Dec 10, 2013·Journal of the Neurological Sciences·Tomor HarnodChia-Hung Kao
Sep 27, 2016·International Journal of Cancer. Journal International Du Cancer·Hong-Bae KimByoungjin Park
Mar 7, 2013·Journal of Neuro-oncology·Mariel B DeutschLisa M Deangelis
Oct 25, 2014·The Oncologist·Jaime Gállego Pérez-Larraya, Jean-Yves Delattre
Sep 1, 2019·Bioelectricity·Paulo R F RochaDavid Tosh

❮ Previous
Next ❯

Related Concepts

Related Feeds

Addison Disease

Addison's disease, also known as primary adrenal insufficiency and hypocortisolism, is a long-term endocrine disorder in which the adrenal glands do not produce enough steroid hormones. Discover the latest research on Addison's disease here.

Related Papers

Journal of Neuro-oncology
N Scott Litofsky, Andrew G Resnick
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology
Ji-An LiangChia-Hung Kao
© 2022 Meta ULC. All rights reserved